Trials / Conditions / Withdrawal Syndrome

Withdrawal Syndrome

9 registered clinical trials studyying Withdrawal Syndrome — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco Use NCT05512091	Cristina Martínez Martínez	—
Completed	Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19 NCT05336656	Wilkes University	—
Completed	AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU) NCT04422808	Wilkes University	—
Completed	Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Facto NCT03996096	University Hospital, Caen	—
Completed	Early Rehabilitation in Critically Ill Children - The PICU Liber8 Study NCT03573479	McMaster University	—
Terminated	Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01) NCT03645603	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Phase 2
Recruiting	Kratom Use Disorder Management Using Clonidine and/or Buprenorphine NCT05883358	Salem Anaesthesia Pain Clinic	—
Completed	Protocolized Sedative Weaning VS. Usual Care in Pediatric Critically Ill, RCT NCT03018977	Ramathibodi Hospital	N/A
Completed	Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in Cerebr NCT03114904	Centre Hospitalier Universitaire, Amiens	N/A